At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
KeraStat(R) Cream +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study: KeraStat(R) Cream for Radiation Dermatitis
In Brief
A clinical study evaluating KeraStat(R) Cream and Standard of care for Radiation Dermatitis. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The primary objectives of the proposed research are to evaluate patient use of KeraStat Cream and collect data to inform a larger future trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRadiation Dermatitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartApr 2018
First PostedJun 2018
Primary CompletionNov 2018
TodayJul 2026
First PostedJun 18, 2018
Enrollment StartApr 11, 2018
Primary CompletionNov 6, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.0 years ago
Interventions
KeraStat(R) Creamdevice
KeraStat Cream is a cream wound dressing that contains 5% keratin.
Standard of careother
Patients will be instructed to follow institutional standard of care for radiation dermatitis